Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Experimental Hematology|July 31, 1999
CD109 is expressed on a subpopulation of CD34+ cells enriched in hematopoietic stem and progenitor cellsL J Murray, E Bruno, N Uchida, et al.Blood|February 9, 2000
Three differentially expressed survivin cDNA variants encode proteins with distinct antiapoptotic functionsE M Conway, S Pollefeyt, J Cornelissen, et al.Current Oncology (Toronto, Ont.)|October 11, 2014
A Canadian consensus on the management of newly diagnosed and relapsed acute promyelocytic leukemia in adultsM D Seftel, M J Barnett, S Couban, et al.Leukemia|September 1, 1990
Chronic myeloid leukemia arising in a progenitor common to T cells and myeloid cellsA C Schuh, D R Sutherland, W Horsfall, et al.Apoptosis : an International Journal on Programmed Cell Death|October 11, 2005
Assessment of the downstream portion of the mitochondrial pathway of caspase activation in patients with acute myeloid leukemiaM Gronda, J Brandwein, M D Minden, et al.Blood Cancer Journal|May 28, 2013
The prognostic impact of FLT3-ITD and NPM1 mutations in patients with relapsed acute myeloid leukemia and intermediate-risk cytogeneticsJ How, J Sykes, M D Minden, et al.Oncogene|April 15, 2008
Evidence of functional interaction between NuMA-RARalpha and RXRalpha in an in vivo model of acute promyelocytic leukemiaM A Sukhai, M Thomas, Y Xuan, et al.Leukemia|March 16, 2011
A phase I/II study of imatinib plus reinduction therapy for c-kit-positive relapsed/refractory acute myeloid leukemia: inhibition of Akt activation correlates with complete responseJ M Brandwein, D W Hedley, S Chow, et al.Leukemia|December 19, 2008
A phase I study of tipifarnib combined with conventional induction and consolidation therapy for previously untreated patients with acute myeloid leukemia aged 60 years and overJ M Brandwein, B F Leber, K Howson-Jan, et al.Current Oncology (Toronto, Ont.)|August 19, 2016
Venous thromboembolism prevention during asparaginase-based therapy for acute lymphoblastic leukemiaH Sibai, J T Seki, T Q Wang, et al.Pageof 3